Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $6.83, but opened at $7.19. Aspen Pharmacare shares last traded at $7.19, with a volume of 221 shares changing hands.
Aspen Pharmacare Price Performance
The stock’s 50-day moving average is $5.70 and its 200 day moving average is $5.99. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.18 and a current ratio of 2.21.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
